| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 8.220 | 14.277 | - | 64.175 | - | - | - | - | - | - |
| Total Income - EUR | 8.220 | 14.277 | - | 64.175 | - | - | - | - | - | - |
| Total Expenses - EUR | 9.529 | 14.040 | - | 12.236 | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | -1.308 | 237 | - | 51.939 | - | - | - | - | - | - |
| Net Profit/Loss - EUR | -1.308 | 237 | - | 50.153 | - | - | - | - | - | - |
| Employees | 1 | 1 | - | 1 | - | - | - | - | - | - |
Check the financial reports for the company - Oncotravel S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 344 | 340 | - | 329 | - | - | - | - | - | - |
| Current Assets | 231.796 | 236.317 | - | 229.230 | - | - | - | - | - | - |
| Inventories | 0 | 137 | - | 132 | - | - | - | - | - | - |
| Receivables | 188.582 | 234.538 | - | 228.219 | - | - | - | - | - | - |
| Cash | 43.214 | 1.642 | - | 879 | - | - | - | - | - | - |
| Shareholders Funds | 13.372 | 13.473 | - | 95.741 | - | - | - | - | - | - |
| Social Capital | 225 | 0 | - | 215 | - | - | - | - | - | - |
| Debts | 218.890 | 223.306 | - | 133.935 | - | - | - | - | - | - |
| Income in Advance | 0 | 0 | - | 0 | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Oncotravel S.r.l.